Filter Results :

Your search for therapies returned 95 reports

Sort by


Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2015

22 Apr 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2015’, provides an overview of the Intra-Cellular Therapies, Inc.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic deve...

$ 1,500.00

Read More

The 2016-2021 World Outlook for Cancer Therapies

01 Apr 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the world outlook for cancer therapies across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is...

$ 995.00

Read More

The 2016 Report on Cancer Therapies: World Market Segmentation by City

01 Apr 2015  |  Published by:  Icon Group International, Inc
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report cov...

$ 995.00

Read More

Immunovative Therapies, Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

25 Mar 2015  |  Published by:  GlobalData
SummaryImmunovative Therapies, Ltd. (ITL) is a biopharmaceutical company. The company develops immunotherapy drug products for treatment of cancer and infectious disease. It offers products that include allovax, allostim, cryostim, indications and animations. ITL develops products based on mirror ef...

$ 250.00

Read More

Intra-Cellular Therapies, Inc. (ITCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

25 Mar 2015  |  Published by:  GlobalData
SummaryIntra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company. It carries out the development of drugs for the treatment of diseases and disorders of the central nervous system. ITI’s products include ITI-007, ITI-002, and ITI-009. The company’s ITI-007, is a clinical stage drug candid...

$ 250.00

Read More

Biotie Therapies Corp. (BTH1V) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

13 Mar 2015  |  Published by:  GlobalData
SummaryBiotie Therapies Corp. (Biotie) is a pharmaceutical company. It discovers and develops medicines for the treatment of neurodegenerative and psychiatric disorders such as Parkinson's disease, Alzheimer's disease and other cognitive disorders; and inflammatory and fibrotic diseases. The company...

$ 250.00

Read More

Biotie Therapies Corp. (BTH1V) - Financial and Strategic SWOT Analysis Review

04 Mar 2015  |  Published by:  GlobalData
SummaryBiotie Therapies Corp. (Biotie) is a pharmaceutical company. It discovers and develops medicines for the treatment of neurodegenerative and psychiatric disorders such as Parkinson's disease, Alzheimer's disease and other cognitive disorders; and inflammatory and fibrotic diseases. The company...

$ 300.00

Read More

Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

04 Mar 2015  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. TTL...

$ 300.00

Read More

Incretin-Based Drugs: Markets for Diabetes Therapies and Developing Treatments

24 Feb 2015  |  Published by:  BCC Research
The global market for incretin-based therapeutics was valued at nearly $11.8 billion in 2013 and $12.7 billion in 2014. This market is expected to reach $22.8 billion by 2019, with a compound annual growth rate (CAGR) of 12.4% from 2014 to 2019. This report provides:-An overview of the glob...

$ 6,650.00

Read More

Vital Therapies, Inc. (VTL) - Medical Equipment - Deals and Alliances Profile

10 Feb 2015  |  Published by:  GlobalData
SummaryVital Therapies, Inc. (Vital Therapies) is a healthcare company. The company provides treatment of liver failure with the development of ELAD. Its ELAD product is a human-cell-based bioartificial liver. Vital Therapies’ ELAD is designed to stabilize liver function in patients with life-threat...

$ 250.00

Read More

Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

10 Feb 2015  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. TTL...

$ 250.00

Read More

Global Rising Stars Outlook 2015: Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets

21 Jan 2015  |  Published by:  MP Advisors
Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets, approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space...

$ 2,000.00
$ 1,800.00
( Save 10% )

Read More

Physician Views: Are dermatologists ready for a new class of psoriasis therapies?

21 Jan 2015  |  Published by:  FirstWord
Novartis has become the first player to bring to market an interleukin-17A inhibitor, most recently announcing on Monday that the European Commission approved Cosentyx for the treatment of moderate-to-severe plaque psoriasis. Approval in the US market for the same indication is also expected in t...

$ 695.00

Read More

Regenerative Medicine and Stem cell based Cell therapies-Drugs of the Future Offering Hope for Cure

21 Jan 2015  |  Published by:  MP Advisors
Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets, approaches and biology is discovered. Improved health care, nutrition and preventive medicine in the last few decades have all helped in increasing the life expectancy WW. However, this has not t...

$ 3,000.00
$ 2,700.00
( Save 10% )

Read More

Advanced Catheter Therapies, Inc. - Medical Equipment - Deals and Alliances Profile

12 Jan 2015  |  Published by:  GlobalData
SummaryAdvanced Catheter Therapies, Inc. (ACT) is an early stage medical device research and development company. The company provides new catheter technologies for vascular disease including inflammation, thrombosis, occlusions and restenosis. ACT is developing a device for restenosis (re-blockage ...

$ 250.00

Read More
Total 95 records.